<DOC>
	<DOCNO>NCT00253591</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray kill tumor cell . Drugs use chemotherapy , vinorelbine cisplatin , work different way stop growth tumor cell , either kill cell stop dividing . It yet know whether give radiation therapy together vinorelbine cisplatin effective radiation therapy alone treat non-small cell lung cancer . PURPOSE : This randomized phase II/III trial study well give radiation therapy together vinorelbine cisplatin work compare radiation therapy alone treat patient stage I , stage II , stage III non-small cell lung cancer .</brief_summary>
	<brief_title>Radiation Therapy With Without Vinorelbine Cisplatin Treating Patients With Stage I , Stage II , Stage III Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare overall survival patient stage I-III non-small cell lung cancer treat vinorelbine , cisplatin , continuous hyperfractionated accelerated radiotherapy ( CHART ) vs CHART alone . Secondary - Compare response , progression-free survival , quality life patient treat regimen . - Compare toxic effect regimens patient . - Compare cost effectiveness regimens patient . - Compare local distant control patient treat regimen . OUTLINE : This randomize , multicenter study . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo continuous hyperfractionated accelerated radiotherapy ( CHART ) 3 time day 12 consecutive day . - Arm II : Patients receive vinorelbine IV 5-10 minute day 1 8 cisplatin IV 2 hour day 1 . Treatment repeat every 21 day 3 course absence disease progression unacceptable toxicity . Beginning 4-6 week later , patient undergo CHART arm I . Quality life assess periodically . After completion study treatment , patient evaluate periodically least 5 year . Peer Reviewed Funded Endorsed Cancer Research UK PROJECTED ACCRUAL : A total 500 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm stage IIII nonsmall cell lung cancer Inoperable patient refuse surgery Disease encompass within radical radiotherapy treatment volume PATIENT CHARACTERISTICS : Performance status ECOG 01 Life expectancy More 3 month Hematopoietic Absolute neutrophil count &gt; 1,500/mm^3 Platelet count &gt; 100,000/mm^3 Hepatic Bilirubin &lt; 1.5 time upper limit normal Renal Glomerular filtration rate &gt; 60 mL/min Cardiovascular No uncontrolled arterial hypertension No ischemic heart disease Pulmonary FEV_1 &gt; 50 % predict OR DLCO &gt; 50 % predict Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No prior current malignancy would preclude study treatment Medically stable No unstable diabetes No infection No hypercalcemia PRIOR CONCURRENT THERAPY : Chemotherapy No prior chemotherapy Radiotherapy See Disease Characteristics No prior radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
</DOC>